Therapeutic potential of SAT-3247 in a canine model of Duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder caused by the loss of functional dystrophin protein, resulting in progressive muscle degeneration in skeletal muscle due to myofiber fragility and muscle stem cell dysfunction. Satellos Biosciences developed an orally available small molecule SAT-3247 to promote repair and regeneration of injured skeletal muscle. SAT-3247 inhibits the kinase AAK1 to increase membrane localization of NUMB, resulting in enhanced polarity, increased numbers of asymmetric divisions, and increased generation of progenitors. Therefore, a pilot study was conducted with a mixed breed DMD canine model to explore the potential for SAT-3247 treatment to impact repair and regeneration of injured skeletal muscle. Two 9-month-old DMD dogs were treated for a period of 18 weeks, with oral delivery of SAT-3247 for 4 consecutive days per week (i.e., 3 days off) at 10 mg/kg dose. SAT-3247 treatment resulted in improved muscle morphology, decreased infiltration of inflammatory cells, increased regenerative index (measuring the ratio of regenerating to necrosing cells) in multiple muscles, improvement in locomotory parameters in both forelimb and hindlimbs including greater force generation with no cardiac toxicity. Overall, this proof-of-concept pilot study in a canine model highlights the therapeutic potential of SAT-3247 to repair and regenerate injured muscle and serve as a treatment for DMD. Together, these data provide a compelling preclinical groundwork for advancing SAT-3247 towards clinical evaluation in DMD patients.

Authors

Institutions

Publication Details

Journal
Skeletal Muscle
Published
2026-11-17
DOI
https://doi.org/10.1186/s13395-026-00463-0
Primary Topic
Muscle Physiology and Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Therapeutic potential of SAT-3247 in a canine model of Duchenne muscular dystrophy

Johnathan K. Smid, Gang Yao, Phil Lambert, Michael A. Rudnicki et al.
2 links
Skeletal Muscle
Muscle Physiology and Disorders
article

Therapeutic potential of SAT-3247 in a canine model of Duchenne muscular dystrophy

Johnathan K. Smid, Gang Yao, Phil Lambert, Michael A. Rudnicki, Jacob G. Monast, James A. Teixeira, Frank Gleeson, Ryan Mitchell, Dongsheng Duan, Yongping Yue, Shanti Rayagiri, Tessa Murray, James Jaquith, Matthew Burke
article en

Abstract

Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder caused by the loss of functional dystrophin protein, resulting in progressive muscle degeneration in skeletal muscle due to myofiber fragility and muscle stem cell dysfunction. Satellos Biosciences developed an orally available small molecule SAT-3247 to promote repair and regeneration of injured skeletal muscle. SAT-3247 inhibits the kinase AAK1 to increase membrane localization of NUMB, resulting in enhanced polarity, increased numbers of asymmetric divisions, and increased generation of progenitors. Therefore, a pilot study was conducted with a mixed breed DMD canine model to explore the potential for SAT-3247 treatment to impact repair and regeneration of injured skeletal muscle. Two 9-month-old DMD dogs were treated for a period of 18 weeks, with oral delivery of SAT-3247 for 4 consecutive days per week (i.e., 3 days off) at 10 mg/kg dose. SAT-3247 treatment resulted in improved muscle morphology, decreased infiltration of inflammatory cells, increased regenerative index (measuring the ratio of regenerating to necrosing cells) in multiple muscles, improvement in locomotory parameters in both forelimb and hindlimbs including greater force generation with no cardiac toxicity. Overall, this proof-of-concept pilot study in a canine model highlights the therapeutic potential of SAT-3247 to repair and regenerate injured muscle and serve as a treatment for DMD. Together, these data provide a compelling preclinical groundwork for advancing SAT-3247 towards clinical evaluation in DMD patients.

Skeletal Muscle
University of Ottawa (CA), Missouri College (US), Ottawa Hospital Research Institute (CA), University of Missouri (US)
University of Ottawa, National Institutes of Health, National Institute of Neurological Disorders and Stroke
Good health and well-being
Muscle Physiology and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon